• Home
  • Research areas
    • ADME-Tox
    • Biomarkers
    • Cell Biology and Signalling
    • Cell Sourcing – Cell Culture Technologies
    • Drug Discovery
    • Gene Expression – Molecular Biology
    • Stem Cells
    • Supplying Discovery Tools
  • Contact us
  • Meet the authors
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Home
Research areas
    ADME-Tox
    Biomarkers
    Cell Biology and Signalling
    Cell Sourcing - Cell Culture Technologies
    Drug Discovery
    Gene Expression - Molecular Biology
    Stem Cells
    Supplying Discovery Tools
Contact us
Meet the authors
tebu-bio's blog - Acting and reacting in life sciences and biotechnologies
  • Home
  • Research areas
    • ADME-Tox
    • Biomarkers
    • Cell Biology and Signalling
    • Cell Sourcing – Cell Culture Technologies
    • Drug Discovery
    • Gene Expression – Molecular Biology
    • Stem Cells
    • Supplying Discovery Tools
  • Contact us
  • Meet the authors
ADME-Tox, Drug Discovery, Headlines, Supplying Discovery Tools

Biomimetic Chemistry, a new route for metabolite synthesis

22/01/2015 by Jean-François Têtu, PhD No Comments

In 2008, the FDA released guidance for drug metabolite safety testing (MIST), emphasizing the importance of metabolite toxicity testing in the drug development process. Indeed, drug toxicity, which accounts for roughly 40% of clinical drug failures, is a leading cause of the high drug attrition rates that have contributed to the skyrocketing drug development costs witnessed over the past few decades.

Traditionally, drug metabolites have been both difficult and hugely expensive to synthesize. Conventional methods of metabolite synthesis, such as those that employ the use of microsomes (while they have proven valuable as a predictive tool, their productive capabilities could be limited by NCE stability) or synthetic chemistry, can be extremely costly and time consuming. Consequently, drugmakers often choose to forego metabolite synthesis (and subsequent metabolite toxicity testing ) early on in the drug development process, opting instead to wait until lead compounds are further along in development before carrying out these essential functions. This decision, perceived to be a calculated risk, ultimately comes at huge price, as drug makers lose millions each year on investments in lead drug candidates that eventually turn out to be failures due to toxicity.

Biomimetic Chemistry, on the other hand, possesses the advantages of both chemistry and biology and is thus a much more efficient tool for metabolite synthesis. In fact, with biomimetic chemistry, large scale metabolite generation is enabled in one step, by mimicking and optimizing the same biotransformation reactions that occur in the liver.

Continue reading
tebu-bio

LAB SERVICES OUTSOURCING

• Protein production

• Plasmid Preps

• 3D Cell Culture
LEARN MORE

Top contributors

Dimitri Szymczak, PhD
Dimitri Szymczak, PhD
  • Adenovirus-based KO
  • New – you know CRISPR, now it’s Prime Editing
Frédéric Samazan
Frédéric Samazan
  • Five new fluorescent probes to easily image live cellular processes
  • Immuno-Oncology: 6 must-haves to boost your projects
Isabelle Nobiron, PhD
Isabelle Nobiron, PhD
  • Accelerate your Biomarker discovery with High Density arrays
  • Want to know more about your Biologics?
Isabelle Topin, PhD
Isabelle Topin, PhD
  • Antibody Purification: Tips and Tricks
  • Monoclonal antibodies – all you need to know about antibody generation
Philippe Fixe, PhD
Philippe Fixe, PhD
  • ChIP for sensitive & fast genomic mapping
  • Recent developments in 3D cell culture hydrogel

Copyright © 2018 - tebu-bio - visit our main website at tebu-bio.com